Nuvectis Pharma Stock (NASDAQ:NVCT), Quotes and News Summary

Q: What sector and industry does Nuvectis Pharma (NVCT) operate in?

Nuvectis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Nuvectis Pharma Stock (NASDAQ: NVCT) stock price, news, charts, stock research, profile.

Open	$6.520
Close	$6.500
Volume / Avg.	21.307K / 92.385K
Day Range	6.430 - 6.610
52 Wk Range	6.200 - 18.650
Market Cap	$115.497M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	8.77%
Days to Cover	7.68

Recent News

10 Short Squeeze Stocks To Watch: Blue Apron, Intuitive Machines, Yellow Corp, Getty Images And More

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.

Chris Katje

Insiders Buying Texas Capital Bancshares And 3 Other Stocks

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.

Lisa Levin

Insiders Buying Steel Connect And 2 Other Stocks

Although US stocks closed mixed on Thursday, there were a few notable insider trades.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Nuvectis Pharma Inc

Sector

Health Care

Industry

Biotechnology

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of inn...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Nuvectis Pharma (NVCT) stock?

You can purchase shares of Nuvectis Pharma (NASDAQ: NVCT) through any online brokerage.

View our list of the best stock brokerages.

Who are Nuvectis Pharma's (NVCT) competitors?

Other companies in Nuvectis Pharma’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB) and FibroGen (NASDAQ:FGEN).

What is the target price for Nuvectis Pharma (NVCT) stock?

The latest price target for Nuvectis Pharma (NASDAQ: NVCT) was reported by HC Wainwright & Co. on Friday, September 15, 2023. The analyst firm set a price target for 21.00 expecting NVCT to rise to within 12 months (a possible 223.08% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Nuvectis Pharma (NVCT)?

The stock price for Nuvectis Pharma (NASDAQ: NVCT) is $6.5 last updated April 26, 2024 at 4:02 PM EDT.

Does Nuvectis Pharma (NVCT) pay a dividend?

There are no upcoming dividends for Nuvectis Pharma.

When is Nuvectis Pharma (NASDAQ:NVCT) reporting earnings?

Nuvectis Pharma’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Is Nuvectis Pharma (NVCT) going to split?

There is no upcoming split for Nuvectis Pharma.

What sector and industry does Nuvectis Pharma (NVCT) operate in?

Nuvectis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-